Sangamo Therapeutics
SGMO
#10605
Rank
A$44.56 M
Marketcap
A$0.11
Share price
0.00%
Change (1 day)
-86.22%
Change (1 year)

Sangamo Therapeutics (SGMO) - Net assets

Net assets on the balance sheet as of March 2026 : -A$27.56 Million

According to Sangamo Therapeutics 's latest financial reports the company has -A$27.56 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Sangamo Therapeutics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$A$0.12 B-71.93%
2022-12-31$A$0.43 B-16.28%
2021-12-31$A$0.51 B-19.96%
2020-12-31$A$0.64 B4.65%
2019-12-31$A$0.61 B18.56%
2018-12-31$A$0.52 B116.6%
2017-12-31$A$0.24 B27.38%
2016-12-31$A$0.18 B-28.47%
2015-12-31$A$0.26 B4.62%
2014-12-31$A$0.25 B85.04%
2013-12-31$A$0.13 B118.5%
2012-12-31$A$62.44 M-20.09%
2011-12-31$A$78.15 M41.99%
2010-12-31$A$55.03 M-31.12%
2009-12-31$A$79.9 M1.77%
2008-12-31$A$78.51 M-4.82%
2007-12-31$A$82.49 M33.52%
2006-12-31$A$61.78 M19.55%
2005-12-31$A$51.67 M23.52%
2004-12-31$A$41.83 M-30.37%
2003-12-31$A$60.08 M-37.6%
2002-12-31$A$96.28 M-40.33%
2001-12-31$A$0.16 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
A$118.50 B-430,218.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$16.98 B-61,761.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$27.39 B-99,535.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
A$25.62 B-93,120.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$17.06 B-62,057.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$61.02 B-221,593.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$5.23 B-19,112.66%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$9.18 B-33,451.04%๐Ÿ‡บ๐Ÿ‡ธ USA